Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-01

Clinical Trial Update: Efficacy and Safety of Peropirone Hydrochloride Tablets in the Treatment of Adolescent Bipolar Disorder Depression [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of Peropirone Hydrochloride tablets for depressive disorders in adolescents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peropirone Hydrochloride Tablets (Peropirone hydrochloride)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Depressive Disorder | Phase 4 | Status: UNKNOWN